Booster Shots

025 - POP II: mobility and coffee, SPAQI pulm, GI and dietary suppl

This is part 2 of a series looking at perioperative medicine, with a few updates from CONVERGE on the effectiveness of mobilization postop and coffee for faster return of bowel function, and a revisit to the Society for Perioperative Quality Improvement (SPAQI) for pulm, GI, and dietary meds. Quick note: we don’t discuss dietary meds in depth at all since there are so many of them and the yield is low, so look to the links below! | 00.44 - Early mobilization is associated with reduced time in the hospital [JAMA Surgery 2023 [https://jamanetwork.com/journals/jamasurgery/fullarticle/2805404]] | | 02.08 - Your local coffee shop’s next bespoke coffee formulation: NGT coffee for early gut mobility! [AJS 2023 [https://doi-org.ucsf.idm.oclc.org/10.1016/j.amjsurg.2023.03.026]] | | 03.04 - SPAQI [https://www.spaqi.org/web/resources-position_papers.php] position paper on Pulmonary and GI associated medications [Mayo clin proc 2021 [https://pubmed.ncbi.nlm.nih.gov/34736777/]] | | 05.14 - SPAQI [https://www.spaqi.org/web/resources-position_papers.php] position paper on Dietary supplements [Mayo Clin proc 2021 [https://pubmed.ncbi.nlm.nih.gov/33741131/]] | | 05.56 - Closing | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.] Music by Amit Apte. Surgery Vectors [https://www.vecteezy.com/free-vector/surgery] by Vecteezy

024 - Addicted to Addiction med w/ Dr. Martin: teaching and consult tips, AUD and gabapentin, and getting to know her

In this episode, we hear the rest of the interview with Dr. Marlene Martin, Hospitalist and Addiction Medicine specialist at SF General. She spoke at CONVERGE, but this year we got to her first! Last episode she discussed some topics around methadone initiation. Today we will here about Dr. Martin’s thoughts on applying these concepts in the hospital, and how YOU can do it too! Other topics include discussing with patients about the the positive urine screen, and gabapentin in the treatment of AUD. Stick around to hear a bit about Dr. Martin’s touristy wishes! | 00.00 - Episode open: WE MEET AGAIN | | 00.41 - Getting motivated and teaching tips | | 03.33 - TOXing with patients about the UTOX | | 11.29 - And a random pearl for those that stick it out to the end, Gabapentin in the treatment of AUD | * Gabapentin For the Treatment of AUD [JAMA 2020 [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2762700], JAMA-IM 2014 [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1764009]] | 15.20 - What got you into Addiction Medicine? | * Beyond the Purple Journal [JHM 2021 [https://shmpublications.onlinelibrary.wiley.com/doi/10.12788/jhm.3732]] | 18.55 - Get to know here: Dr. Martin and South America | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.] Music by Amit Apte. Cover art organized by Neal Tambe.

023 - Addiction med w/ Dr. Marlene Martin: Methadone and QTc, faster titration, depots and more!

In this episode, we say Hi to all our new listeners after SHM, we are glad you are joining us and hope you stick around! Make sure to follow on your platform of choice. Today we are broadcasting part 1 of an interview with Dr. Marlene Martin, an addiction medicine specialist who works at the SF General. We talk to her about methadone initiation issues including faster initiation, QTc checks, and pain management during an admission. Note: this episode is provided for informational purposes only. We do not directly endorse the use of these discussions, including CAM2038, without proper input from your local addiction medicine consultants. | 00.00 - Episode open: HELLO TO OUR NEW LISTENERS! | | 00.48 -Intro to Dr. Marlene Martin | | 01.53 - Latine v Latinx - ask people how they want to be referred to! | | 03.08- Methadone and checking the QTc | | 09.34 - What happens outpatient with the EKG and the QTc? | | 10.04 - Discussing needs with other groups. Its a team effort! | | 11.14 - Methadone changes and EKG followup | | 12.07 - COMING SOON: FASTER METHADONE TITRATION (spoiler, don’t do it yet without addiction medicine guidance) | * CAM2038 as a possible depot option. Studies are currently being done | 17.15 - What to do with pain on top of methadone or Buprenorphine | * Rapid Clinical Updates: Inpatient Management of Opioids [SHM 2023 [https://www.shmlearningportal.org/content/rapid-clinical-updates-inpatient-management-opioid-withdrawal-fentanyl-era]] * Marlene’s paper “Inhospital substance use policies” [JAM 2023 [https://journals.lww.com/journaladdictionmedicine/fulltext/2023/01000/in_hospital_substance_use_policies__an_opportunity.4.aspx]] | 24.53 - Closing | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.] Music by Amit Apte. Cover art organized by Neal Tambe.

022 - CONVERGE, EMPA-CKD, abx @ EOL, and ketamine in the ED

Before we head off to SHM CONVERGE this weekend, here are a few articles that may be of use in your practice. A random assortment from end-of-life care to ketamine in pain control, hopefully its something for everyone. | 00.05 - Intro | | 00.48 - CONVERGE - come visit me on Saturday in Hall F! Or email boostershots@ucsd.edu [boostershots@ucsd.edu] if you want to discuss at other times! | | 01.42 - Empagliflozin delays CKD progression in diabetic or glomerular disease, but not necessarily hypertensive or renovascular disease [ACP Journal Club 2024 [https://www.acpjournals.org/doi/10.7326/J24-0020] (subscription required), Lancet D&E 2024 [https://www.sciencedirect.com/science/article/pii/S2213858723003224?via%3Dihub]] | 03.14 - Antibiotics and end of life care - I recommend you look at the paper [CID 2024 [https://academic.oup.com/cid/article/78/3/e27/7596076?login=true]] | | 06.33 - Low dose ketamine for pain control vs. morphine → Shorter onset, but shorter duration [AJEMEN 2024 [https://www.sciencedirect.com/science/article/pii/S073567572300668X?ref=cra_js_challenge&fr=RR-1]] | 08.00 - Using Deep Learning models to estimate CV risk using CXR only [AIM 2024 [https://www.acpjournals.org/doi/10.7326/M23-1898#core-r10-M231898]] * references for the groups’ other studies using Deep Learning: Long-term mortality from CXR [JAMA 2019 [https://doi.org/10.1001/jamanetworkopen.2019.7416]], Identifying high risk smokers for lung cancer CT screening [AIM 2020 [https://doi.org/10.7326/M20-1868]]\ | 09.53 - 43s Summary (yes I lied, it wasn’t 30s), disclaimers, credits, etc. | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.]

021 - Dr. Lewin and RD Shah on IBD, Fecal Transplants, albumin and vasoactives - AGA updates

Taking a look at some of the American Gastroenterological association guidelines from the past 6 months that covers Fecal Microbiota Transplantation, IBD biomarkers and dietary recommendations, and a few more updates in ascites and cirrhosis management via albumin and vasoactive medications. | 00.00 - Intro | 00.52 - FMT [AGA 2024 [https://doi.org/10.1053/j.gastro.2024.01.008]] | | 03.31 - The use of Biomarkers in Crohn’s Disease [Gastro 2023 [https://www.gastrojournal.org/article/S0016-5085(23)05064-3/fulltext]] + a quick call do Dr. Sara Lewin, inpatient IBD specialist at UCSF | | 10.42 - IBD dietary recommendations [AGA 2024 [https://gastro.org/clinical-guidance/diet-and-nutritional-therapies-in-patients-with-ibd/]] + a chat with RD Neha Shah, IBD dietary specialist at UCSF | | 22.26 - Albumin, vasoactives, and ascites [AGA 2022 [https://doi.org/10.1016/j.cgh.2022.08.033]] | | 24.24 - Summary | [The appearance of external hyperlinks does not constitute endorsements by UCSF of the linked websites, or the information, products, or services contained therein. UCSF does not exercise any editorial control over the information found therein, nor does UCSF make any representation of their accuracy or completeness. All information contained in this episode are the opinions of the respective speakers and not necessarily the views their respective institutions or UCSF, and is only provided for information purposes, not to diagnose or treat.] Music by Amit Apte. Image generated using Copilot.